Multiplex immunofluorescence: Antibodies and panels for MICS spatial biology
Multiplex immunofluorescence: Antibodies and panels for MICS spatial biology
You need a clear picture of what's going on. That involves labeling the right markers, specifically, consistently, and reproducibly. And that’s why we alone produce both platform and reagents for spatial biology experiments. Our fluorochrome-conjugated MACS® Antibodies have undergone extensive testing with MICS (MACSima™ Imaging Cyclic Staining) technology on the MACSima Platform, ensuring they deliver the performance you need.
Explore the world's largest antibody portfolio for spatial biology, targeting over 600 biomarkers of human or mouse origin for FFPE and frozen sections. Our recombinant antibody technology seamlessly supports our automated MICS protocol, and we can even get you going with same-section multiomics. With our ever-growing portfolio and ever-expanding pre-testing to save you valuable time, your multiplex immunofluorescence experiments will pioneer new frontiers in understanding nature's complexity.
Save experimental time and effort
Our pre-tested antibodies reduce the need for preliminary experiments, saving you time when developing a panel for a new experiment.
Start from a solid foundation, not from scratch
Our REAplex Pre-defined panel is compiled and tested to show key markers in your sample – and it comes with comprehensive guidance from experimental design to data analysis.
Comprehensive insights at the push of a button
Visualize the tumor microenvironment in detail with our comprehensive REAscreen Immuno-Oncology Panel. Skip panel establishment and dive into your sample right away.
Explore our pre-tested antibodies and pre-defined panels for spatial biology
I'm most impressed by the MACSima Platform's antibody technology. Miltenyi Biotec's extensive portfolio of pre-tested antibodies is striking: so many antibodies, and they work!
The MICS technology principle
1144 products found
|
You have previously chosen International as your location.
What do you want to do?